Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
0 hedge funds and large institutions have $0 invested in Mural Oncology in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 61 closing their positions.
30.72% less ownership
Funds ownership: 30.72% → 0% (-31%)
100% less funds holding
Funds holding: 61 → 0 (-61)
100% less capital invested
Capital invested by funds: $11M → $0 (-$11M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 61
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$1.22M |
| 2 |
NM
Newtyn Management
New York
|
-$1.08M |
| 3 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$1.06M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$941K |
| 5 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
-$631K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$46 | -22 | Closed |
|
52
Jones Financial Companies
Des Peres,
Missouri
| – | -$21 | -10 | Closed |
|
|
PS
53
Principal Securities
Des Moines,
Iowa
| – | -$21 | -10 | Closed |
|
|
MCM
54
MAI Capital Management
Independence,
Ohio
| – | -$15 | -7 | Closed |
|
|
NA
55
NewEdge Advisors
New Orleans,
Louisiana
| – | -$10 | -5 | Closed |
|
56
Citigroup
New York
| – | -$8 | -4 | Closed |
|
|
SC
57
SouthState Corp
Winter Haven,
Florida
| – | -$6 | -3 | Closed |
|
|
FFA
58
Farther Finance Advisors
San Francisco,
California
| – | -$2 | -1 | Closed |
|
|
TCM
59
TD Capital Management
Memphis,
Tennessee
| – | -$2 | -1 | Closed |
|
MURA Hedge Fund Activity: Q4 2025 in Review
0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2025, worth a combined $0 — down 100% from $11M a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of MURA and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was OrbiMed, exiting entirely with an estimated $1.22M sold.
- 0 institutional investors held Mural Oncology (MURA) as of Q4 2025, down from 61 in Q3 2025.
- Funds reported $0 of Mural Oncology stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Mural Oncology positions in Q4 2025 and 61 closed out, a net change of -61 holders.
- The largest Mural Oncology seller in Q4 2025 was OrbiMed, an estimated $1.22M sold.
Based on aggregated 13F filings for Q4 2025.